Cargando…

Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer

This phase II randomized clinical trial aimed to assess the efficacy and toxicity of Endostar, an antiangiogenesis inhibitor, combined with concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer (LACC). Patients with LACC were randomly assigned to either CCRT plus Endostar (CCRT+E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Heming, Wu, Yuying, Liu, Xu, Huang, Huixian, Jiang, Hailan, Zhu, Chaohua, Man, Yuping, Chen, Zhaohong, Long, Xianfeng, Pang, Qiang, Peng, Luxing, Li, Xianglong, Gu, Junzhao, Deng, Shan, Xing, Ligang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790112/ https://www.ncbi.nlm.nih.gov/pubmed/34544526 http://dx.doi.org/10.3727/096504021X16318716607908

Ejemplares similares

The Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Treatment Response for Cervical Cancer Treated with Concurrent Chemoradiotherapy
por: Lu, Heming, et al.
Publicado: (2021)

Long-Term Results of Concurrent Chemoradiotherapy Combined with Anti-EGFR Monoclonal Antibody Prior to Surgery in Locally Advanced Cervical Cancer: A Single-Institute Prospective Study
por: Qing, Defeng, et al.
Publicado: (2020)

A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer
por: Lu, Heming, et al.
Publicado: (2018)

Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy
por: Huang, Huixian, et al.
Publicado: (2015)

Three-Phase Adaptive Radiation Therapy for Patients With Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiation Therapy: Dosimetric Analysis
por: Deng, Shan, et al.
Publicado: (2017)

Dosimetric study of a respiratory gating technique based on four-dimensional computed tomography in non-small-cell lung cancer
por: Lin, Hui, et al.
Publicado: (2014)

The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma
por: Guan, Ying, et al.
Publicado: (2015)

Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
por: Yin, Yuanxiu, et al.
Publicado: (2022)

A Clinical-Radiomics Nomogram Based on Computed Tomography for Predicting Risk of Local Recurrence After Radiotherapy in Nasopharyngeal Carcinoma
por: Zhu, Chaohua, et al.
Publicado: (2021)

Intrathoracic Endotracheal Metastasis from Nasopharyngeal Carcinoma: A First Case Report and Review of the Literature
por: Lu, Heming, et al.
Publicado: (2010)

Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers
por: Chen, Weijie, et al.
Publicado: (2011)

Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy
por: Ji, Yanzhen, et al.
Publicado: (2023)

Cavity development: a potential biomarker for antiangiogenesis agents
por: Jiang, Man, et al.
Publicado: (2020)

Monitoring antiangiogenesis of bevacizumab in zebrafish
por: Zhang, Jing, et al.
Publicado: (2018)

The Efficacy and Safety of Continuous Intravenous Endostar Treatment Combined With Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: A Randomized Controlled Trial
por: Shu, Hang, et al.
Publicado: (2021)

Endostar Rebuilding Vascular Homeostasis and Enhancing Chemotherapy Efficacy in Cervical Cancer Treatment
por: Guan, Liming
Publicado: (2020)

Interobserver Variations in Target Delineation in Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinoma and its Impact on Target Dose Coverage
por: Liu, Xu, et al.
Publicado: (2023)

Surrogate markers in antiangiogenesis clinical trials
por: Davis, D W, et al.
Publicado: (2003)

Antiangiogenesis in recurrent glioblastoma: proof of principle
por: Nossek, Erez, et al.
Publicado: (2009)

Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
por: Wan, Xueting, et al.
Publicado: (2021)

Intensity-modulated radiation therapy (IMRT)-based concurrent chemoradiotherapy (CCRT) with Endostar in patients with pelvic locoregional recurrence of cervical cancer: Results from a hospital in the Qinghai-Tibet Plateau
por: Zhang, Kuan, et al.
Publicado: (2020)

The Treatment Combining Antiangiogenesis with Chemoradiotherapy Impinges on the Peripheral Circulation Vascular Endothelial Cells and Therapeutic Effect in the Patients with Locally Advanced Nasopharyngeal Carcinoma
por: Gong, Xiuyun, et al.
Publicado: (2022)

Antiangiogenesis therapy: an update after the first decade
por: De Falco, Sandro
Publicado: (2014)

Clinical Trials of Antiangiogenesis Therapy on Gastric Cancer
por: Wu, Li Cun, et al.
Publicado: (2008)

Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer()
por: Ribatti, Domenico, et al.
Publicado: (2016)

Hypertension and Antiangiogenesis: The Janus Face of VEGF Inhibitors
por: Touyz, Rhian M., et al.
Publicado: (2019)

Isthmin inhibits glioma growth through antiangiogenesis in vivo
por: Yuan, Bangqing, et al.
Publicado: (2012)

From antiangiogenesis to hypoxia: current research and future directions
por: Rice, Christopher, et al.
Publicado: (2010)

Emerging roles for antiangiogenesis factors in management of ocular disease
por: Saeed, Muhammad Usman, et al.
Publicado: (2013)

Antiangiogenesis and antioxidant activity of ethanol extracts of Pithecellobium jiringa
por: Muslim, Nahdzatul Syima, et al.
Publicado: (2012)

Antitumor effects of different administration sequences of cisplatin and Endostar on Lewis lung carcinoma
por: FAN, JUAN, et al.
Publicado: (2015)

Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis
por: Yuan, Meng, et al.
Publicado: (2021)

Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation
por: Hu, Sanyuan, et al.
Publicado: (2010)

Primary pulmonary arterial sarcoma treated with endostar injection and radiotherapy
por: Xu, Hui, et al.
Publicado: (2020)

Primary pulmonary arterial sarcoma treated with Endostar injection and radiotherapy
por: Xu, Hui, et al.
Publicado: (2020)

Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L
por: Birmpas, Charalampos, et al.
Publicado: (2012)

The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis
por: Ribatti, Domenico
Publicado: (2010)

Development and validation of the functional assessment of cancer therapy–antiangiogenesis subscale
por: Kaiser, Karen, et al.
Publicado: (2015)

Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis
por: Wang, Ji, et al.
Publicado: (2016)

Recent progress toward antiangiogenesis application of nanomedicine in cancer therapy
por: Mukherjee, Sudip
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d91kkqn8skofruqrrhjo62klqd